Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)
| 6.87 Data as of Jun 19 |  -0.20 / -2.83%Today’s Change | 3.78 Today|||52-Week Range 10.48 | +40.20% Year-to-Date |
Latest SCMP News | Press Releases
No recent news for Sucampo Pharmaceuticals Inc.
Today’s Trading
| Previous close | 7.07 |
| Today’s open | 7.05 |
| Day’s range | 6.78 - 7.08 |
| Volume | 117,690 |
| Average volume (3 months) | 278,495 |
| Market cap | $296.7M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +8.33% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +48.80% |
| P/E ratio | 76.3 |
| Price/Sales | 2.51 |
| Price/Book | 6.90 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| STMLStemline Therapeutic... | +0.54 | +2.22% |
| VNDAVanda Pharmaceutical... | -2.41 | -22.07% |
| THLDThreshold Pharmaceut... | -0.04 | -0.73% |
| ENTAEnanta Pharmaceutica... | +0.02 | +0.11% |
Data as of 4:00pm ET, 06/19/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | $0.19 |
| Annual revenue (last year) | $81.5M |
| Annual profit (last year) | $4.8M |
| Net profit margin | 5.93% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, Chief Executive & Scientific Officer Ryuji Ueno, MD, PhD |
Chief Accounting Officer Andrew P. Smith, DBA |
Corporate headquarters Bethesda, Maryland |
Forecasts
